Trial Profile
Pharmacokinetics of Lisdexamfetamine (Vyvanse®) in Post-bariatric Surgery Patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Aug 2020
Price :
$35
*
At a glance
- Drugs Lisdexamfetamine (Primary)
- Indications Attention-deficit hyperactivity disorder; Eating disorders; Mood disorders
- Focus Pharmacokinetics
- 12 May 2017 Status changed from not yet recruiting to recruiting.
- 07 Mar 2017 New trial record